These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31284566)

  • 1. The Foundation Fighting Blindness Plays an Essential and Expansive Role in Driving Genetic Research for Inherited Retinal Diseases.
    Shaberman B; Durham T
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31284566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non-profit foundation.
    Mansfield BC; Yerxa BR; Branham KH
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):838-845. PubMed ID: 32783387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium.
    Durham TA; Duncan JL; Ayala AR; Birch DG; Cheetham JK; Ferris FL; Hoyng CB; Pennesi ME; Sahel JA;
    Transl Vis Sci Technol; 2021 Apr; 10(4):23. PubMed ID: 34004001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer therapeutic options for inherited retinal diseases: Gene and cell replacement therapy.
    Battu R; Ratra D; Gopal L
    Indian J Ophthalmol; 2022 Jul; 70(7):2316-2325. PubMed ID: 35791112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Non-Human Primate Models of Inherited Retinal Diseases.
    Seah I; Goh D; Chan HW; Su X
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and cell-based therapies for inherited retinal disorders: An update.
    Sengillo JD; Justus S; Tsai YT; Cabral T; Tsang SH
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):349-366. PubMed ID: 27862925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of people with inherited retinal conditions toward gene editing technology.
    Hoffman-Andrews L; Mazzoni R; Pacione M; Garland-Thomson R; Ormond KE
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00803. PubMed ID: 31190471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
    Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM
    Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene Therapy for Inherited RETINAL AND OPTIC NERVE Disorders: Current Knowledge].
    Ďuďáková Ľ; Kousal B; Kolářová H; Hlavatá L; Lišková P
    Cesk Slov Oftalmol; 2016; 72(4):128-136. PubMed ID: 27860478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in research on pathogenic genes and gene therapy for inherited retinal diseases].
    Zhu L; Cao C; Sun J; Gao T; Liang X; Nie Z; Ji Y; Jiang P; Guan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):118-123. PubMed ID: 28186610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
    Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
    PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.
    Xue K; MacLaren RE
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1163-1170. PubMed ID: 32741234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for RPE65-related retinal disease.
    Miraldi Utz V; Coussa RG; Antaki F; Traboulsi EI
    Ophthalmic Genet; 2018 Dec; 39(6):671-677. PubMed ID: 30335549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optometrist's guide to the top candidate inherited retinal diseases for gene therapy.
    O'Hare F; Edwards TL; Hu ML; Hickey DG; Zhang AC; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):431-443. PubMed ID: 33689629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation's Perspective.
    Yerxa B
    Pharm Res; 2018 Oct; 35(11):239. PubMed ID: 30338398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Viral Gene Therapy Clinical Trials for Retinal Diseases.
    Cheng SY; Punzo C
    Hum Gene Ther; 2022 Sep; 33(17-18):865-878. PubMed ID: 36074935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.
    Koenekoop RK; Sui R; Sallum J; van den Born LI; Ajlan R; Khan A; den Hollander AI; Cremers FP; Mendola JD; Bittner AK; Dagnelie G; Schuchard RA; Saperstein DA
    Lancet; 2014 Oct; 384(9953):1513-20. PubMed ID: 25030840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy and genome surgery in the retina.
    DiCarlo JE; Mahajan VB; Tsang SH
    J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preface of Special Issue "Molecular Therapies for Inherited Retinal Diseases".
    Collin RWJ; Garanto A
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.